marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
CannBioRx Life Sciences Corp. Financial Statements 2011-2025 | ATNFW
Annual Financial Statements CannBioRx Life Sciences Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
38 K | 31.4 K | - | - | - | - | - | - | - | - | - | - |
Shares |
1.9 M | 1.57 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
0.02 | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-38.7 M | -20.3 M | - | 423 K | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-17.9 M | -15.6 M | -5.65 M | -20.9 M | -599 K | -344 K | - | - | - | - | - | - |
Interest Expense |
36.4 K | 25.4 K | 185 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-17.8 M | -15.5 M | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
17.9 M | 15.6 M | - | 1.21 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.61 K | 463 K | - | 1.21 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement CannBioRx Life Sciences Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
981 K | 919 K | 638 K | 535 K | 419 K | 275 K | 197 K | 3.75 M | 1.96 M | 1.71 M | 1.7 M | 34 M | 32.7 M | 31.5 M | 28 M | 26.2 M | 16.9 M | 16.9 M | 4.46 M | 13.8 M | 4.26 M | 4.23 M | 4.1 M | 4.1 M | 4.17 M | 4.18 M | 4.2 M | 4.2 M | 4.22 M | 2.85 M | 2.5 M | 2.5 M | 2.5 M | 2.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-837 K | 11.8 K | -1.07 M | - | -10.3 M | -3.68 M | -4.76 M | - | -21.5 M | 2.94 M | 1.56 M | - | 18.3 M | -23.5 M | -16.2 M | - | -829 K | 267 K | -2.38 M | - | -21.8 K | -10.8 K | 232 K | - | 320 K | 211 K | 173 K | - | 86.1 K | 5.29 K | -31.3 K | -3.1 K | -683 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 408 K | - | - | - | 3.01 M | - | - | - | 767 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-979 K | -1.85 M | -2.09 M | - | -3.54 M | -3.68 M | -4.8 M | - | -4.06 M | -4.52 M | -3.68 M | - | -4.22 M | -4.01 M | -2.95 M | - | -731 K | -934 K | -1.57 M | - | -226 K | -296 K | -265 K | - | -140 K | -148 K | -138 K | - | -141 K | -50.4 K | -31.3 K | -3.1 K | -683 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 16.4 K | - | 11.6 K | 11.6 K | 11.6 K | - | 7.35 K | 7.36 K | 28.1 K | - | 5.46 K | 12.2 K | 104 K | - | 83 K | 172 K | 185 K | - | 255 K | 356 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -2.07 M | - | - | - | -4.78 M | - | -4.06 M | -4.52 M | -3.68 M | - | -4.22 M | -4.01 M | -2.95 M | - | -731 K | -934 K | -1.57 M | - | -226 K | -296 K | -265 K | - | -140 K | -148 K | -138 K | - | -141 K | -50.4 K | -31.3 K | -3.1 K | -683 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
979 K | 1.85 M | 2.09 M | - | 3.54 M | 3.68 M | 4.8 M | - | 4.06 M | 4.52 M | 3.68 M | - | 4.22 M | 4.01 M | 2.95 M | - | 731 K | 934 K | 1.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
563 K | 1.22 M | 234 K | - | 2.43 M | 80.6 K | 471 K | - | 3.42 M | - | 5.26 K | - | 82.5 K | 340 K | 39.1 K | - | 1.79 M | 3.51 M | 995 K | - | 226 K | 296 K | 265 K | - | 140 K | 148 K | 138 K | - | 141 K | 50.4 K | 31.3 K | 3.1 K | 683 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency